Benson Heather A E, Namjoshi Sarika
School of Pharmacy, Curtin University of Technology, PO Box U 1987, Perth, Western Australia 6845, Australia.
J Pharm Sci. 2008 Sep;97(9):3591-610. doi: 10.1002/jps.21277.
Despite the increased availability of therapeutic proteins and peptides, delivery remains almost entirely via hypodermic needle. Transdermal delivery offers an attractive noninvasive route of administration but is limited by the skin's barrier to penetration. Extensive research has been directed at developing effective methods to enhance delivery of peptides and proteins to and across the skin. Strategies include formulation optimisation, conjugation to increase peptide lipophilicity and incorporation of chemical or biological modifiers to transiently reduce stratum corneum barrier function. A number of physical technologies, including iontophoresis, electroporation and sonophoresis, have been developed that apply different forms of energy to disrupt the barrier. In addition, minimally invasive techniques, such as microneedles and jet propulsion, bypass the stratum corneum barrier to permit direct access to the viable epidermis. This article reviews the current state of the art in the delivery of proteins and peptides to and across the skin.
尽管治疗性蛋白质和肽的可获得性有所提高,但给药方式几乎仍完全是通过皮下注射针。经皮给药提供了一种有吸引力的非侵入性给药途径,但受到皮肤渗透屏障的限制。大量研究致力于开发有效的方法来增强肽和蛋白质向皮肤内及透过皮肤的递送。策略包括制剂优化、通过共轭作用增加肽的亲脂性以及加入化学或生物改性剂以暂时降低角质层屏障功能。已经开发了多种物理技术,包括离子导入、电穿孔和超声导入,这些技术应用不同形式的能量来破坏屏障。此外,微针和喷射推进等微创技术绕过角质层屏障,从而能够直接进入有活力的表皮。本文综述了蛋白质和肽向皮肤内及透过皮肤递送的当前技术水平。